Carisma Presents Pre-Clinical Proof of Concept for in vivo C

Carisma Presents Pre-Clinical Proof of Concept for in vivo CAR-M using mRNA platform in collaboration with Moderna at SITC

/PRNewswire/ -- Carisma Therapeutics Inc. (Nasdaq: CARM) ("Carisma" or the "Company"), a clinical stage biopharmaceutical company focused on discovering and...

Related Keywords

Philadelphia , Pennsylvania , United States , Lin Guey , Prnewswire Carisma Therapeutics Inc , Exchange Commission , Society For Immunotherapy Of Cancer , Company Quarterly Report On Form , Research Ventures At Moderna , Nasdaq , Exchange Commission On , Carisma Therapeutics Inc , Annual Meeting , Chief Scientific Officer , External Research Ventures , Private Securities Litigation Reform Act , Quarterly Report ,